Insiders · Profile

Anderson Woodrow D

Chief Accounting Officer at Indivior Pharmaceuticals. Filing since 5 Aug 2026. CIK 0002014440

Company
Date
Role
Action
Shares
Amount
Of holding
27 Aug 2026
Chief Accounting Officer
Bought
1,500
$53.54K
5.7%
5 Aug 2026
Chief Accounting Officer
Bought
1,500
$54.42K
6.1%
2 decisions on file.